SIGA TECHNOLOGIES INC. overview

Edison Investment Research Limited Edison Investment Research Limited: SIGA Technologies (SIGA): Initiation - Protection against a future pandemic 05-March-2021 / 12:00 GMT/BST London, UK, 5 March 2021 SIGA Technologies (SIGA): Initiation - Protection against a future pandemic SIGA Technologies is a commercial-stage company focusing on health security. Its lead program is oral TPOXX (tecovirimat), which was approved by the FDA in 2018 for the treatment of smallpox and is active against all...

NEW YORK, June 15, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the United States Department of Defense (DoD), via the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense’s (JPEO-CBRND) Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical), has increased research and development...